Hoth Therapeutics, Inc.
HOTH
$0.8687
-$0.021-2.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.91% | -12.97% | -16.64% | -20.48% | -31.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.30% | -17.25% | -22.54% | -26.26% | -28.13% |
| Operating Income | -3.30% | 17.25% | 22.54% | 26.26% | 28.13% |
| Income Before Tax | -1.02% | 19.26% | 24.13% | 27.50% | 28.72% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.02% | 19.26% | 24.13% | 27.50% | 28.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.02% | 19.26% | 24.13% | 27.50% | 28.72% |
| EBIT | -3.30% | 17.25% | 22.54% | 26.26% | 28.13% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 46.47% | 69.09% | 71.67% | 73.22% | 73.92% |
| Normalized Basic EPS | 45.10% | 66.15% | 69.77% | 71.45% | 72.74% |
| EPS Diluted | 46.47% | 69.09% | 71.67% | 73.22% | 73.92% |
| Normalized Diluted EPS | 45.10% | 66.15% | 69.77% | 71.45% | 72.74% |
| Average Basic Shares Outstanding | 87.08% | 113.28% | 128.36% | 146.29% | 184.67% |
| Average Diluted Shares Outstanding | 87.08% | 113.28% | 128.36% | 146.29% | 184.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |